Mohammed S. Taghour

Design, synthesis, molecular modeling and anti-proliferative evaluation of novel quinoxaline derivatives as potential DNA intercalators and topoisomerase II inhibitors

M.K. Ibrahim, Mohammed S. Taghour, Ahmed M. Metwaly et al. · European Journal of Medicinal Chemistry · 2018 · 129 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

New benzoxazole derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, anti-proliferative evaluation, flowcytometric analysis, and <i>in silico</i> studies

Hazem Elkady, Alaa Elwan, Hesham A. El‐Mahdy et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2021 · 122 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Discovery of new pyrimidine-5-carbonitrile derivatives as anticancer agents targeting EGFR^WTand EGFR^T790M

Ahmed Abdel Nasser, Ibrahim H. Eissa, Mohamed R. Oun et al. · Organic & Biomolecular Chemistry · 2020 · 120 citations

Pharmacy, Medicinal Chemistry, Oncology +14

Design and synthesis of thiazolidine-2,4-diones hybrids with 1,2-dihydroquinolones and 2-oxindoles as potential VEGFR-2 inhibitors: <i>in-vitro</i> anticancer evaluation and <i>in-silico</i> studies

Mohammed S. Taghour, Hazem Elkady, Wagdy M. Eldehna et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2022 · 99 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +12

Design and discovery of new 1,2,4‐triazolo[4,3‐<i>c</i>]quinazolines as potential DNA intercalators and topoisomerase II inhibitors

Mohamed S. Alesawy, Ahmed A. Al‐Karmalawy, Eslam B. Elkaeed et al. · Archiv der Pharmazie · 2020 · 76 citations

Pharmacy, Medicinal Chemistry, Pharmacology +13